We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INN
1076
Summit Hotel Properties
INN
$761M
| $942K | ﹤0.01% |
76,357
+7,096
| +10% | +$85.2K |
|
1077
Ambarella
AMBA
$2.99B
| $941K | ﹤0.01% |
15,531
-459
| -3% | -$25.4K |
|
1078
Baker Hughes
BKR
$56.8B
| $941K | ﹤0.01% |
36,704
+1,284
| +4% | +$29.2K |
|
1079
Houlihan Lokey
HLI
$9.68B
| $938K | ﹤0.01% |
19,182
-163
| -0.8% | -$7.69K |
|
1080
Portland General Electric
POR
$6.02B
| $938K | ﹤0.01% |
16,806
+290
| +2% | +$16.2K |
|
|
SIVB
1081
DELISTED
SVB Financial Group
SIVB
| $934K | ﹤0.01% |
3,718
+1,750
| +89% | +$398K |
|
|
PRSP
1082
DELISTED
Perspecta Inc. Common Stock
PRSP
| $931K | ﹤0.01% |
35,216
+614
| +2% | +$16.4K |
|
1083
East-West Bancorp
EWBC
$17.9B
| $928K | ﹤0.01% |
19,047
+14,488
| +318% | +$653K |
|
1084
SiriusXM
SIRI
$10B
| $925K | ﹤0.01% |
12,933
+210
| +2% | +$14.2K |
|
1085
Commault Systems
CVLT
$5.89B
| $924K | ﹤0.01% |
20,700
-167
| -0.8% | -$7.9K |
|
1086
First Interstate BancSystem
FIBK
$3.7B
| $922K | ﹤0.01% |
21,971
+4
| +0% | +$168 |
|
1087
Unifirst Corp
UNF
$5.32B
| $921K | ﹤0.01% |
4,559
+647
| +17% | +$131K |
|
1088
Invesco S&P 500 Low Volatility ETF
SPLV
$7.2B
| $919K | ﹤0.01% |
15,746
+4,018
| +34% | +$231K |
|
1089
Builders FirstSource
BLDR
$7.84B
| $918K | ﹤0.01% |
36,100
-4,809
| -12% | -$115K |
|
1090
Cheesecake Factory
CAKE
$4.21B
| $918K | ﹤0.01% |
23,626
+1,609
| +7% | +$66.3K |
|
1091
HF Sinclair
DINO
$15.9B
| $913K | ﹤0.01% |
17,994
+60
| +0.3% | +$3.18K |
|
1092
Canadian Imperial Bank of Commerce
CM
$107B
| $911K | ﹤0.01% |
21,896
-446
| -2% | -$18.9K |
|
|
LSI
1093
DELISTED
Life Storage, Inc.
LSI
| $910K | ﹤0.01% |
12,606
-14
| -0.1% | -$1K |
|
1094
GoDaddy
GDDY
$12.3B
| $907K | ﹤0.01% |
13,335
+15
| +0.1% | +$992 |
|
1095
Takeda Pharmaceutical
TAK
$55.1B
| $905K | ﹤0.01% |
45,883
-5,438
| -11% | -$104K |
|
|
IIN
1096
DELISTED
IntriCon Corporation
IIN
| $905K | ﹤0.01% |
50,294
-3,350
| -6% | -$64.2K |
|
|
HOLX
1097
DELISTED
Hologic
HOLX
| $902K | ﹤0.01% |
17,278
+6,286
| +57% | +$313K |
|
1098
Restaurant Brands International
QSR
$25.1B
| $900K | ﹤0.01% |
14,117
-137
| -1% | -$9.17K |
|
1099
Molson Coors Class B
TAP
$7.68B
| $900K | ﹤0.01% |
16,686
+2,633
| +19% | +$142K |
|
1100
NovoCure
NVCR
$2.04B
| $894K | ﹤0.01% |
10,611
-300
| -3% | -$24.2K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.